Table 1. Human oncogenic viruses and their interactions with the host DNA damage response.
Oncogenic virus | Tumors associated with virus infection | Oncoproteins involved in DDR | References |
---|---|---|---|
EBV | Burkitt's lymphoma, post-transplant lymphoma, non-Hodgkin's/diffuse large B cell lymphomas, nasopharyngeal carcinoma, gastric carcinoma | EBNA2/LP → DDR | (Nikitin et al, 2010) |
EBNA1 → ROS → DDR | (Gruhne et al, 2009a) | ||
EBNA3C ⊣ early DDR | (Nikitin et al, 2010) | ||
EBNA3C⊣Chk2,p53 | (Choudhuri et al, 2007; Yi et al, 2009) | ||
EBNA3C⊣ G2/M checkpoint | (Gruhne et al, 2009b; Parker et al, 2000) | ||
LMP1⊣ATM | (Gruhne et al, 2009b) | ||
KSHV | Kaposi's sarcoma, primary effusion lymphoma | v-cyclin → ATM | (Koopal et al, 2007) |
LANA → myc → DDR | (Liu et al, 2007) | ||
LANA:p53 | (Chen et al, 2010; Friborg et al, 1999) | ||
HPV | Cervical cancer, ovarian cancer | E6,E7 → repl stress → DDR | (Bester et al, 2011) |
E7:pATM | (Moody and Laimins, 2009) | ||
E6⊣p53 | (Scheffner et al, 1990) | ||
HBV | Hepatocellular carcinoma | HBV → ATR | (Wang et al, 2008; Zhao et al, 2008a) |
HBx → Ras → DDR | (Klein and Schneider, 1997) | ||
HBx ⊣ p53 | (Wang et al, 1994) | ||
HTLV I | ATL | Tax⊣DNA-PK | (Durkin et al, 2008) |
Tax⊣Chk1/Chk2 | (Park et al, 2004; Park et al, 2006) | ||
Tax⊣p53 | (Ariumi et al, 2000; Pise-Masison et al, 2000) |
Abbreviations: ATL=adult T-cell leukaemia; DDR=DNA damage response; EBV=Epstein–Barr virus; HBV=hepatitis B virus; HPV=human papillomavirus; HTLV-I=human T-lymphotropic virus type I.